What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes

to investigate prognostic significance of many factors in MDS including HALP score ( haemoglobin level, albumin level, lymphocyte, platelets), monocytopenia, hyperfibrinogenemia and AST/ALT ratio in patients with MDS at Assiut University Hospital. And to study overall survival and leukemia free survival rates in MDS patients.

NCT Number	NCT07210034
Lead Sponsor	Assiut University
Conditions	Myelo Dysplastic Syndrome
Enrollment	100 participants
Start Date	2026-01-01
Primary Completion	2028-01-01 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-10-07